Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Adults With Autoimmune Disease (V212-009) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and immunogenicity of an inactivated Varicella Zoster Virus vaccine in adults with autoimmune disease (V212-009) complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• Inactivated Varicella Zoster Virus Vaccine (Varicella Zoster Virus vaccine (inactivated))

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Herpes Zoster | Phase 2 | Status: COMPLETED | Results posted: 2019-01-14